Sixty five Japanese patients with lung cancer showed a high incidence of Keap1 somatic mutations [62] and in breast cancer a Keap1 (C23Y) mutation impaired its ability to repress Nrf2 [63]. Here, KEAP1 is linked to breast carcinoma.